United States Senate Caucus on International Narcotics Control
Jurisdiction
The Senate Caucus on International Narcotics Control was created to “monitor and encourage United States Government and private programs seeking to expand international cooperation against drug abuse and narcotics trafficking” and to “monitor and promote international compliance with narcotics control treaties.” As a formal organization of the U.S. Senate, the Caucus has the status of a standing committee. The Caucus exercises oversight on a wide range of issues, including international counternarcotics assistance and domestic drug prevention and treatment programs. The Caucus has held numerous hearings over the years and has issued a number of reports on U.S. narcotics control policy.
United States Senate Caucus on International Narcotics Control — official siteJurisdiction text and membership come from the official roster; the sectors above are our reading of that jurisdiction.
Roster
| Member | Seat | Overlap events |
|---|---|---|
| RJohn Cornyn | ChairmanLeadership | 0 |
| DSheldon Whitehouse | ChairmanLeadership | 0 |
| RChuck Grassley | Member | 0 |
| DRichard Blumenthal | Member | 0 |
| DBen Ray Luján | Member | 0 |
| RJames E. Risch | Member | 0 |
| RBernie Moreno | Member | 0 |
Most traded in the sectors it oversees
Committee overlap Estimated
The committee-to-sector tags are our editorial judgement, not an official classification: a committee is mapped where its published jurisdiction covers an industry's regulation, funding or oversight. Broad money committees are deliberately left unmapped. Rosters are current-Congress membership only, so an overlap is shown only for trades on or after January 3, 2025, and only for members serving today.
An overlap of duty and holding is not an allegation of insider trading or of any other violation.
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice.